---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Drugs Approved for Thyroid Cancer - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/thyroid
version: v1
---

# Drugs Approved for Thyroid Cancer - NCI

# Drugs Approved for Thyroid Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here.

## Drugs Approved for Thyroid Cancer

- [Cabozantinib-S-Malate](/about-cancer/treatment/drugs/cabozantinib-s-malate)
- [Caprelsa (Vandetanib)](/about-cancer/treatment/drugs/vandetanib)
- [Cometriq (Cabozantinib-S-Malate)](/about-cancer/treatment/drugs/cabozantinib-s-malate)
- [Dabrafenib Mesylate](/about-cancer/treatment/drugs/dabrafenib)
- [Doxorubicin Hydrochloride](/about-cancer/treatment/drugs/doxorubicinhydrochloride)
- [Gavreto (Pralsetinib)](/about-cancer/treatment/drugs/pralsetinib)
- [Lenvatinib Mesylate](/about-cancer/treatment/drugs/lenvatinibmesylate)
- [Lenvima (Lenvatinib Mesylate)](/about-cancer/treatment/drugs/lenvatinibmesylate)
- [Mekinist (Trametinib Dimethyl Sulfoxide)](/about-cancer/treatment/drugs/trametinib)
- [Nexavar (Sorafenib Tosylate)](/about-cancer/treatment/drugs/sorafenibtosylate)
- [Pralsetinib](/about-cancer/treatment/drugs/pralsetinib)
- [Retevmo (Selpercatinib)](/about-cancer/treatment/drugs/selpercatinib)
- [Selpercatinib](/about-cancer/treatment/drugs/selpercatinib)
- [Sorafenib Tosylate](/about-cancer/treatment/drugs/sorafenibtosylate)
- [Tafinlar (Dabrafenib Mesylate)](/about-cancer/treatment/drugs/dabrafenib)
- [TrametinibÂ Dimethyl Sulfoxide](/about-cancer/treatment/drugs/trametinib)
- [Vandetanib](/about-cancer/treatment/drugs/vandetanib)
